Previous studies have also shown that some chemical drugs with the ability to induce IDILI also cause NLRP3 inflammasome activation in vitro by inducing the release of DAMPs from damaged or dead cells, suggesting that NLRP3 inflammasome activation may be a critical mechanism of some drug-mediated idiosyncratic liver injury [19]. The gene discussed is NLRP3; the disease is injury.